![Han Myint](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Han Myint formerly worked at NexImmune, Inc., as Chief Medical Officer, Celgene LLC, as Vice President-Global Medical Affairs, the University of Colorado Denver, as Professor-Medicine, and NextCure, Inc., as Chief Medical Officer from 2021 to 2024.
Dr. Myint received his undergraduate degree from the University of Medicine 1.
Eerdere bekende functies van Han Myint
| Bedrijven | Functie | Einde |
|---|---|---|
| NEXTCURE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2024 |
University of Colorado Denver
 University of Colorado Denver Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Celgene LLC | Corporate Officer/Principal | - |
| NEXIMMUNE, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Han Myint
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
2
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Celgene LLC | |
University of Colorado Denver
University of Colorado Denver Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
University of Medicine 1
 University of Medicine 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies MarketScreener 
